Skip to main content

Day: October 17, 2025

Protext Mobility, Inc. (OTC: TXTM) Announces Plans for Corporate Website Redesign and Investor Relations Suite to Enhance Transparency and Shareholder Engagement

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) — Protext Mobility, Inc. (OTC: TXTM), an emerging leader in botanical-based biotechnology, today announced its strategic initiative to redesign its corporate website and develop a dedicated Investor Relations (IR) Suite, as part of the company’s commitment to transparency, regulatory compliance, and proactive investor communication. This planned digital transformation reflects Protext’s mission to improve stakeholder access to timely, accurate, and comprehensive company information. The IR Suite will serve as a centralized hub for financial reports, regulatory filings, press releases, shareholder communications, and governance disclosures—empowering shareholders, institutional investors, and regulatory authorities with real-time insights into the company’s operations and milestones. “Our...

Continue reading

Tradewinds Universal (OTC: TRWD) Announces BizTrendWatch Coverage and Interview with Alan Chang

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) — Tradewinds Universal, Inc. (OTC: TRWD) announced today that BizTrendWatch, a multimedia platform covering trends across business, politics, entertainment, and market culture, has initiated coverage on the Company and released its first exclusive interview with Alan Chang, CEO of Peppermint Hippo and Director at TRWD. BizTrendWatch has begun producing a series of televised and digital segments highlighting Tradewinds Universal’s expansion strategy and its partnership with Peppermint Hippo, one of the fastest-growing brands in adult nightlife. The coverage features executive interviews, streaming features, and influencer-driven content, offering investors consistent insight as the Company and Peppermint Hippo move forward together on their national growth venture. In addition to the initial...

Continue reading

Regarding the income level of the Networks segment’s electricity distribution services for 2026

AB “Ignitis grupė” (hereinafter – the Group) informs that, pursuant to the Methodology for determining the price caps for electricity transmission, distribution and public supply services (link in Lithuanian), on 17 October 2025, National Energy Regulatory Council (hereinafter – NERC) adopted the resolution on the price caps for electricity distribution services and other regulatory components of AB “Energijos skirstymo operatorius” (hereinafter – ESO) for 2026 (hereinafter – the Resolution) (link in Lithuanian). Income level of electricity distribution services and other regulatory components for 2026      2026 2025 Change Change, %Income cap  EURm 376.9 321.6 55.3 17,2%RAB1  EURm 1,655.1 1,540.5 114.6 7,4%WACC2  % 5.77 5.82 (0.05 pp) n/aDepreciation and amortisation (regulatory)  EURm 97.8 88.6 9.2 10,4%Additional tariff...

Continue reading

Vocodia Holdings Corp. and Scale Agile Solutions Announce Letter of Intent for Strategic Asset Acquisition

BOCA RATON, Fla., Oct. 17, 2025 (GLOBE NEWSWIRE) — Vocodia Holdings Corp. (OTC: VHAI) (“Vocodia”), a leader in conversational AI solutions, and AdRetreaver LLC d/b/a Scale Agile Solutions (SAS), a provider of innovative AI-driven technologies, today announced the signing of a non-binding Revised Letter of Intent (LOI) for a strategic asset acquisition. The proposed transaction will see Vocodia acquire SAS’s technology, intellectual property, and commercial contracts, positioning the combined entity to expand its presence in the $470 billion conversational AI market. Strategic Transaction Overview Under the terms outlined in the LOI, Vocodia will acquire key SAS assets while Connexus Ai Inc., a separate entity, will remain privately held and excluded from the transaction. Post-closing, SAS will operate as an independent division...

Continue reading

Warner Bros. Veteran Jeffrey Schlesinger Joins Kartoon Studios Board of Directors

Former President of Warner Bros. Worldwide Television Distribution, and Global Distribution Leader Behind “Friends,” “The Big Bang Theory,” and “Two and a Half Men” Schlesinger Oversaw World’s Largest Animation Catalogue Including Warner Bros., Hanna-Barbera, and MGM Animation BEVERLY HILLS, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) — Kartoon Studios (NYSE American: TOON), a leading global producer and distributor of premium children’s and family entertainment, today announced the appointment of Jeffrey Schlesinger — former President of Warner Bros. Worldwide Television Distribution and one of the most accomplished executives in global media — to its Board of Directors. Schlesinger brings more than three decades of operational, strategic, financial, and deal-making expertise, having built Warner Bros.’ worldwide television business...

Continue reading

Nukkleus Inc. Announces Filing of Corporate-Sponsored SPAC Registration Statement

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) — Nukkleus, Inc. (NASDAQ:NUKK) (“Nukkleus” or the “Company”) announced that it is the majority owner of the sponsor of a newly formed special purpose acquisition company (“SPAC”) named SC II Acquisition Corp. (“SC II”). On October 16, 2025, SCII filed a registration statement on Form S-1 with the Securities and Exchange Commission (“SEC”) in connection with a proposed initial public offering (“IPO”) of its units. SCII intends to raise $150 million in the proposed IPO through the sale of units. Each unit is expected to have an offering price of $10.00 and consists of one Class A ordinary share and one right to receive one fifth (1/5) of a Class A ordinary share upon the consummation of an initial business combination. SCII also expects to grant the underwriters an option to purchase up to...

Continue reading

Vera Therapeutics Announces ORIGIN 3 Late-Breaking Abstract Selected as Featured Oral Presentation at Opening Plenary Session of ASN Kidney Week 2025

BRISBANE, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that data from the ORIGIN Phase 3 clinical trial of atacicept for the treatment of IgA nephropathy (IgAN) will be delivered as a featured late-breaking oral presentation during the opening plenary session of the American Society of Nephrology (ASN) Kidney Week 2025 in Houston, Texas, being held November 6 to 9. In addition, two informational posters will describe the ORIGIN Extend and PIONEER trials of atacicept in IgAN and other autoimmune mediated glomerular diseases. ASN Kidney Week 2025 Presentation DetailsTitle: ORIGIN 3: A Phase 3 Trial of Atacicept in IgANPresenting...

Continue reading

WeightWatchers Launches RxFlexFund™, a New Employer Model for Expanding GLP-1 Coverage

Provides a Differentiated Cost-Sharing Framework for GLP-1 Medications Paired With Clinical Oversight and Proven Behavior Change Support from WeightWatchers Clinic NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) — WW International, Inc. (NASDAQ: WW) (“WeightWatchers” or the “Company”), the global leader in science-backed weight management, today announced the launch of WeightWatchers RxFlexFund™, a first-of-its-kind solution that combines direct pricing from pharmaceutical manufacturers with flexible employer subsidy coverage for GLP-1s, integrated with WeightWatchers’ full-spectrum behavioral and clinical support. With WeightWatchers RxFlexFund, employers cover the cost of WeightWatchers Clinic and contribute a set percentage of medication costs, ranging from 25% to 75%, to help offset the impact of GLP-1 medication costs for...

Continue reading

24/7 Market News: VENU Hits High Notes as Sunset Amphitheater Momentum Sparks Next Phase

DENVER, Oct. 17, 2025 (GLOBE NEWSWIRE) — 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, reports that VENU (NYSE American: VENU), a growing operator of premium hospitality and live entertainment venues across the U.S., is tuning up for its most ambitious act yet as it leverages a string of breakthrough milestones, including the unveiling of multi-season amphitheater renderings, record-setting FireSuite sales, and the backing of high-profile stakeholders like Dierks Bentley, to set the stage for a $5 billion construction pipeline and a national network of 20+ next-generation amphitheaters. VENU’s recently revealed Sunset Amphitheater renderings for McKinney, Texas and Broken Arrow, Oklahoma have generated major industry buzz. These are no ordinary...

Continue reading

Brazil Potash Announces $28 Million Private Placement

MANAUS, Brazil, Oct. 17, 2025 (GLOBE NEWSWIRE) — Brazil Potash Corp. (NYSE American: GRO) (“Brazil Potash” or the “Company”), a mineral exploration and development company with a critical mineral potash mining project, the Autazes Project, today announced that it has entered into a private placement financing with certain institutional and accredited investors for the sale of an aggregate of 11,450,000 Common Units and 2,550,000 Pre-Funded Units. Each Common Unit is comprised of one common share of the Company and one common stock purchase warrant to purchase one common share (“Common Warrants”). Each Pre-Funded Unit is comprised of one pre-funded warrant to purchase one common share (“Pre-Funded Warrants”) and one Common Warrant. Each Common Unit has a purchase price of $2.00, and each Pre-Funded Unit has...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.